Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (11)
9.
Roufosse, C., Lespagnard, L., Sales, F., Bron, D., & Dargent, J.-L. (1998). Langerhans' cell histiocytosis associated with simultaneous lymphocyte predominance Hodgkin's disease and malignant melanoma. Human pathology, 29(2), 200-201. doi:10.1016/S0046-8177(98)90236-210.
Aoun, M., Jacquy, C., Debusscher, L., Bron, D., Lehert, M., Noël, P., & Van Der Auwera, P. (1992). Peripheral neuropathy associated with fluoroquinolones [30]. Lancet, 340(8811), 127. Participations à des congrès et colloques internationaux (42)
1.
Michiels, S., Bron, D., Crombez, P., Meuleman, N., Kirakoya, F., & Tricas-Sauras, S. (2019). A prospective approach of migrants and ethnic minorities in order to overcome poor adherence and to guarantee an equal access to innovative transplant procedures. In S. Michiels, D. Bron, P. Crombez, N. Meuleman, F. Kirakoya, & S. Tricas-Sauras (Eds.), NO009 A prospective approach of migrants and ethnic minorities in order to overcome poor adherence and to guarantee an equal access to innovative transplant procedures: Vol. 54 (p. 620–634) Bone Marrow Transplantation.2.
Michiels, S., Bron, D., Crombez, P., Vercruyssen, M., Tricas-Sauras, S., & Kirakoya, F. (2019). Oral anticancer medication adherence of migrants and ethnic minorities with haematological malignancies, a challenge for EBMT? In S. Michiels, D. Bron, P. Crombez, M. Vercruyssen, S. Tricas-Sauras, & F. Kirakoya (Eds.), O185 Oral anticancer medication adherence of migrants and ethnic minorities with haematological malignancies, a challenge for EBMT?: Vol. 54 (p. 678–680) Quality Management Group – Oral Session: Bone Marrow Transplantation.3.
Dubruille, S., Kenis, C., Thibaud, V., Libert, Y., Delforge, M., Dal Lago, L., Roos, M., Borghgraef, C., Pepersack, T., Wildiers, H., & Bron, D. (2018). Cognitive Impairment, Hypoalbuminemia, High CRP Level and Past History of Gastro-Intestinal Ulcer: 4 Markers of Frailty Which Identify Older Patients with Malignant Hemopathies Who Shouldn't Benefit from Chemotherapy. Blood,(132), 4756.4.
Michiels, S., Crombez, P., Salaroli, A., Nguyen Thi, T., Boulanovitch, J., Abdelouahhab, O., Szcepanska, S., & Bron, D. (2017). Do we need to address cross-cultural issues in EBMT ? Paper session presented at THE 43RD ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (March 26th-29th 2017: Marseille, France).5.
Dubruille, S., Kenis, C., Libert, Y., Delforge, M., Alexis Ruyz, J., Roos, M., Collard, A., Meuleman, N., Maerevoet, M., Razavi, D., Wildiers, H., & Bron, D. (2017). A new frailty scoring in "clinically fit” older patients with malignant hemopathies admitted to receive chemotherapy. Abstracts of the 32th General Annual Meeting of the Belgian Hematological Society Abstract session presented at 32th General Annual Meeting of the Belgian Hematological Society(Dolce la Hulpe)6.
Dubruille, S., Kenis, C., Libert, Y., Delforge, M., Choffray, C., Roos, M., Collard, A., Meuleman, N., Maerevoet, M., Razavi, D., Wildiers, H., & Bron, D. (2016). How to predict poor outcome in older patients receiving chemotherapy for malignant lymphoma: a new frailty scoring. Blood,(128), 2353.7.
Dubruille, S., Libert, Y., Roos, M., Vandenbossche, S., Collard, A., Meuleman, N., Maerevoet, M., Etienne, A.-M., Reynaert, C., Razavi, D., & Bron, D. (2016). Identification of clinical and biological parameters predictive of chemotherapy completion and two-year overall survival in clinically fit older patients with haematological malignancies. Abstracts of the 31th General Annual Meeting of the Belgian Hematological Society Abstract session presented at 31th General Annual Meeting of the Belgian Hematological Society(Dolce la Hulpe)8.
Dubruille, S., Kenis, C., Libert, Y., Delforge, M., Alexis Ruyz, J., Roos, M., Collard, A., Meuleman, N., Maerevoet, M., Razavi, D., Wildiers, H., & Bron, D. (2016). A new frailty scoring in "clinically fit” older patients with malignant hemopathies admitted to receive chemotherapy. Abstracts of the 16th International Society of Geriatric Oncology Abstract session presented at 16th International Society of Geriatric Oncology(Milan)9.
Dubruille, S., Libert, Y., Alexis Ruyz, J., Roos, M., Collard, A., Meuleman, N., Maerevoet, M., Razavi, D., & Bron, D. (2015). Underestimated impact of mild cognitive impairment in « clinically fit » older patients with malignant hemopathies admitted to receive chemotherapy. Haematologica,(10), 145.